Emphasys Plans 2008 Launch Of Bronchial Valve For Emphysema
This article was originally published in The Gray Sheet
Executive Summary
Emphasys Medical is gearing up for a "late 2008" U.S. launch of its Emphasys Bronchial Valve implant for emphysema, funded in part by a proposed initial public stock offering worth up to $86.3 million (see chart: "1Emphasys Medical IPO")